← Back to all trials
Completed
NCT06370039
Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
Conditions: Dry Eye Disease
Sex: All
Ages: 18 Years – 74 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 109
Sponsor: Invirsa, Inc.
Location: iuvo BioScience Rush New York
Summary
Phase 2 study to assess the efficacy of topically administered eyedrops of INV-102 during 4-week repeat dosing in subjects with moderate to severe dry eye disease.
Eligibility Criteria
Key Inclusion Criteria:
* Subjects ≥18 and \
Source: ClinicalTrials.gov (NCT06370039). StuddyBuddy aggregates publicly available trial information.
